지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2020.1
- 수록면
- 52 - 55 (4page)
이용수
초록· 키워드
오류제보하기
Abstract Pulmonary arterial hypertension (PAH) is known as one of diseases with the worst prognosis. Recently, targeted PAH drugs have been developed and approved for use; therefore, the treatment strategy and goals have changed, and the prognosis has improved over two decades. We reviewed the case of a female who showed the natural disease course of heritable PAH in treatment with the targeted PAH drugs under the Korean Health Insurance policy. At the age of 15, she visited the outpatient clinic for dyspnea on exertion that occurred 3 years ago. At that time, severe pulmonary hypertension was revealed by an echocardiography and there was no evidence of significant shunt lesion or embolism. After 4 years of loss to follow-up, her performance was WHO functional class III and she still suffered from dyspnea. The initial monotherapy using an endothelin receptor antagonist was started in 2008. After 2 years, BMPR 2 mutation was detected. Her clinical symptoms gradually worsened because of poor compliance. To escalate therapy, combination therapy was given, and finally, triple maximal therapy was maintained. The next step is to consider intravenous prostanoids. Various combinations of targeted therapy have been tried, and several trials have been confirmed that improve the prognosis. Initial upfront combination therapy and a more enthusiastic approach make good a better prognosis. In this area, active support of the government insurance policy is indispensable in Korea.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Stem Cell and Exosome Therapy in Pulmonary Hypertension
Korean Circulation Journal
2022 .02
-
Epidemiology of PAH in Korea: An Analysis of the National Health Insurance Data, 2002–2018
Korean Circulation Journal
2023 .05
-
Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
Clinical Hypertension
2022 .01
-
Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension
Journal of Korean Medical Science
2015 .01
-
New Therapeutic Target for Pulmonary Arterial Hypertension
Korean Circulation Journal
2018 .01
-
Clinical Presentation with High Penetrance in a Korean Family with Pulmonary Arterial Hypertension Associated with a BMPR2 Intron 3 Splice Site Pathogenic Variant
Laboratory Medicine Online
2018 .01
-
A Nationwide multicenter registry and biobank program for deep phenotyping of idiopathic and hereditary pulmonary arterial hypertension in Korea: the PAH platform for deep phenotyping in Korean subjects (PHOENIKS) cohort
Clinical Hypertension
2019 .01
-
Hypoxic pulmonary vasoconstriction and vascular contractility in monocrotaline-induced pulmonary arterial hypertensive rats
The Korean Journal of Physiology & Pharmacology
2016 .11
-
Current Trends and Movements in Managing Pulmonary Arterial Hypertension in Korea
Korean Circulation Journal
2023 .05
-
한국 성인의 소변 중 PAHs 대사체 노출수준 및 영향요인에 관한 연구
환경독성보건학회 심포지엄 및 학술대회
2019 .10
-
The standards for recognition of occupational cancers related with polycyclic aromatic hydrocarbons (PAHs) in Korea
대한직업환경의학회지
2018 .03
-
VEGF Promoter Polymorphism Confers an Increased Risk of Pulmonary Arterial Hypertension in a Chinese Population
Yonsei Medical Journal
2017 .01
-
Hyponatremia Associated with Pulmonary Arterial Hypertension: Syndrome of Inappropriate Antidiuresis Versus Right Heart Failure
Electrolytes & Blood Pressure
2020 .01
-
Chronic Thromboembolic Pulmonary Hypertension: Endovascular Treatment
Korean Circulation Journal
2019 .01
-
The Clinical Efficacy of Pulmonary Hypertension-Specific Agents in Idiopathic Pulmonary Fibrosis: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Journal of Korean Medical Science
2020 .01
-
Prevalence of Pulmonary Arterial Hypertension in Korean Adult Patients with Systemic Sclerosis: Result of a Pilot Echocardiographic Screening Study
Journal of Cardiovascular Imaging
2016 .12
-
Risks and management of hypertension in cancer patients undergoing targeted therapy: a review
Clinical Hypertension
2022 .01
-
Clinical characteristics and prognosis of patients with very severe acute hypertension visiting the emergency department
Clinical Hypertension
2022 .01
-
Pulmonary Arterial Hypertension is Normalized Following Six Years of Inhaled Iloprost Treatment in a Patient with Systemic Sclerosis
대한류마티스학회지
2017 .01
-
Effective Postoperative Use of Dexmedetomidine in a Child with Severe Pulmonary Arterial Hypertension Secondary to Congenital Ventricular Septal Defect
Acute and Critical Care
2015 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0